Member of Lyonbiopole
Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins. Adocia’s portfolio of injectable treatments for diabetes, featuring five clinical-stage products and three preclinical products, is among the largest and most differentiated of the industry.
Strategic application domain: Human Medicine
Application market: Metabolic Disorders - Endocrinology, Others
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Others
Created on dec. 22nd, 2005 - 100 employees
Address
115 avenue Lacassagne 69003 LYON
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.